• Phase 1: the revolution is ongoing!
    Phase 1: the revolution is ongoing!
    A revolution is ongoing, which has already changed and will continue to change the role of phase 1 studies in oncology drug development.
  • Registration
    Registration for TAT 2017 is open. Register now and take advantage of attractive early-bird rates!
  • Abstract Submission
    Abstract Submission
    Abstract submission for TAT 2017 is open. Submit your abstract before the deadline of January 6 and compete for one of the Best-Poster Awards!
  • Important dates
    Important dates
  • Exhibitor & Support Opportunities
    Exhibitor & Support Opportunities
    Act now to identify the best strategies at TAT 2017 to ensure maximum results for your company in this dynamic marketplace.
  • TAT 2016 report
    TAT 2016 report
    A brief report of TAT 2016 is online now. Over the three days of the conference, 45 oral presentations covered 23 unique new drugs or drug classes in early-phase clinical trials at the time of the conference.